Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
PCBs at NC State: Dorms, library, classroom buildings test positive
Recommended
Analysis: Carolina's decision to draft Bryce Young over C.J. Stroud requires accountability
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
BLCO
)
18.95
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about BLCO
< Previous
1
2
3
4
5
6
Next >
7 Analysts Have This to Say About Bausch & Lomb
December 21, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
December 21, 2022
Via
Benzinga
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
December 13, 2022
Benzinga Sam Bankman-Fried Arrested In The Bahamas
Via
Benzinga
What 7 Analyst Ratings Have To Say About Bausch & Lomb
November 23, 2022
Via
Benzinga
Expert Ratings for Bausch & Lomb
November 03, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
December 13, 2022
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO).
Via
Benzinga
What 4 Analyst Ratings Have To Say About Bausch & Lomb
October 11, 2022
Analysts have provided the following ratings for Bausch & Lomb (NYSE:BLCO) within the last quarter:
Via
Benzinga
What 4 Analyst Ratings Have To Say About Bausch & Lomb
September 12, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Expert Ratings for Bausch & Lomb
September 12, 2022
Within the last quarter, Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
September 12, 2022
Upgrades
Via
Benzinga
Expert Ratings for Bausch & Lomb
August 16, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
'Well-Established' Eye Health Company Bausch + Lomb Gets Outperform Rating From This Analyst
July 26, 2022
Via
Benzinga
From Corporate Raider To Activist Investor: Here Are Three High-Yielding Stocks Carl Icahn Favors
August 28, 2022
Formerly known as a "corporate raider," Carl Icahn is the founder and controlling shareholder of Icahn Enterprises, which is a large holding company with well diversified positions.
Via
Benzinga
BHC Stock Continues to Fall as Bausch Health Responds to Court Decision
July 29, 2022
Although Bausch Health promises to fight back against an unfavorable patent protection ruling, BHC stock is still hurting.
Via
InvestorPlace
Bausch Health (BHC) Stock Plunges 50% on Patent News
July 28, 2022
With Bausch Health losing a critical patent battle enabling its key drug to suffer generic competition, BHC stock veritably crumbled.
Via
InvestorPlace
Meta, Charter Communications, Southwest Airlines And Some Other Big Stocks Moving Lower On Thursday
July 28, 2022
Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan.
Via
Benzinga
Expert Ratings for Bausch & Lomb
July 26, 2022
Bausch & Lomb (NYSE:BLCO) has observed the following analyst ratings within the last quarter:
Via
Benzinga
IPO Market Posts Slowest Quarter Since Great Recession
June 24, 2022
IPOs in the second quarter plunged to the lowest level since the Great Recession in 2009, led by health care and technology.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Thursday
July 28, 2022
On Thursday, 108 companies set new 52-week lows.
Via
Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
Gainers
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
July 26, 2022
Upgrades
Via
Benzinga
7 Ways to Prepare for a Recession: An Investor’s Guide
June 24, 2022
There are plenty of ways to prepare for a recession. Here are seven ways you can make sure you're ready for whatever comes next.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022
June 24, 2022
Upgrades
Via
Benzinga
2 Cheap Stocks Trading at “Deal of the Century” Prices
June 10, 2022
Simple value metrics are provenly bad at generating consistent returns, but that doesn't mean there aren't opportunities to be found.
Via
InvestorPlace
Expert Ratings for Bausch & Lomb
June 09, 2022
Over the past 3 months, 7 analysts have published their opinion on Bausch & Lomb (NYSE:BLCO) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
3 Value Stocks That Could 2x in a Recession
June 02, 2022
It might be tempting to say that valuation metrics are no longer useful for certain kinds of value stocks, but you need to adjust your focus.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2022
May 31, 2022
Upgrades
Via
Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
May 30, 2022
Biotech stocks advanced in the week ended May 27, tracking the overall positive sentiment of the broader market. Notwithstanding the week's strength, the sector has been one of the worst performers for...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 11, 2022
May 11, 2022
Upgrades
Via
Benzinga
Bausch Health (BHC) Stock Plunges 25% After Bausch + Lomb IPO
May 10, 2022
Bausch Health (BHC) stock is falling on Tuesday following the release of its earnings report for the first quarter of 2022.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.